Study compares single-inhaler triple therapies for treatment of COPD
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according to ...
Manchester Journal1d
Ounce of Prevention: What is an abnormal office blood pressure?
Ounce of Prevention is a weekly column which presents recommendations for preventative services derived from The United States Preventive Services Task Force (USPSTF). Each column begins with the name ...
GlobalData on MSN1d
UK MHRA approves MSD’s pulmonary arterial hypertension therapy
MSD has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for sotatercept, marketed as ...
Health on MSN1d
What's the Difference Between Left- and Right-Sided Heart Failure?
Medically reviewed by Angela Ryan Lee, MD Heart failure occurs when the heart can't pump blood as well as it should. It can ...
londonlovesbusiness.com2d
When breathing becomes a challenge, expert support makes a big difference
Seek expert support for respiratory issues from pulmonologists. Learn how they diagnose and manage lung diseases for better ...
MedPage Today5d
Have the New Pulmonary Hypertension Drugs Changed the Game?
After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...